Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Director | April 26, 2012 | April 27, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date April 26, 2012 · Filed April 27, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,773.2 |
Reported balance
After 2012-04-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2012-04-26 · Grant · Acquired 5,962.7 · Balance 23,773.2 F1: Each unit represents one phantom share of common stock. F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2012 Filed Apr 27, 2012 21:39 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,962.7 | $23.06 | $137,499.86 |
DisclosureSEC source: 0001225208-12-010382 · doc4.xml · derivative · entry 1 MASCOTTE JOHN P · CIK 0001113681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,773.2 Underlying: Common Stock · 5,962.7 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 28, 2011 Filed Apr 28, 2011 19:40 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-012438 · doc4.xml · derivative · entry 1 MASCOTTE JOHN P · CIK 0001113681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,092 Underlying: Common Stock · 5,500 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 22, 2010 Filed Apr 26, 2010 14:09 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-010892 · doc4.xml · derivative · entry 1 MASCOTTE JOHN P · CIK 0001113681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,107 Underlying: Common Stock · 5,500 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| October 15, 2009 Filed Oct 19, 2009 18:34 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000229 · primary_doc.xml · derivative · entry 2 MASCOTTE JOHN P · CIK 0001113681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F4 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F4 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| October 15, 2009 Filed Oct 19, 2009 18:34 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 3,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000078003-09-000229 · primary_doc.xml · nonDerivative · entry 1 MASCOTTE JOHN P · CIK 0001113681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,940 F1 · price: Received (together with $33.00 in cash for each share of Wyeth common stock) in exchange for 4,000, shares of Wyeth common stock in connection with the acquisition of Wyeth by Pfizer Inc. (the "Acquisition"). On the closing date of the Acquisition, the closing price of Wyeth's common stock was $50.39 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.